The Brigham Board Review in Hematology and Oncology 2016
Brigham and Women’s Hospital Board Review
- Oakstone Price: $1895.
- Format: 58 Video Files (.mp4 format) + 2 PDF files.
- File Size: 18.3 GB.
- Download Link Below.
This post contains protected content. You must contact us to unlock it.
Stay Current with this CME Board Review in Hematology and Oncology
The Brigham Board Review in Hematology and Oncology is designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. This case-based board review will help you prep for certification/recertification with an in-depth look at the clinical essentials in both specialties. You’ll learn to:
- Perform differential diagnosis of complex hematologic and oncologic disorders
- Identify and apply current therapeutic options for hematologic and oncologic disorders
- Evaluate and interpret up-to-date literature relevant to hematology and oncology
- Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
Discover New Guidelines
A clinically based update, this learn-at-your-own-pace course in hematology and oncology provides a maximum of 44.5 AMA PRA Category 1 Credits ™ and 44.5 MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.
Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Oakstone Publishing, LLC designates this enduring material for a maximum of 44.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 44.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Date of Original Release: June 30, 2016
Termination Date: June 30, 2019
CME credit is awarded upon successful completion of a course evaluation and post-test.
Upon completion of this activity, the participant will be able to:
- Apply current/recommended Hematology and Oncology guidelines in clinical practice
- Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
- Identify/apply current therapeutic options for for specific Hematologic and Oncologic disorders
- Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
- Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
- Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations
This course is designed to provide hematology/oncology fellows/trainees, hematologists, oncologists and internists with new knowledge and management strategies to enhance the care of their patients, as well prepare candidates for the ABIM subspecialty board exams in hematology or medical oncology.
- Molecular Genetics of Cancer – Levi A. Garraway, MD, PhD
- Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD
- Infections in Cancer Patients – Joel T. Katz, MD
- Symptom Management in Patients with Cancer – Janet L. Abrahm, MD
- Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD
- Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
- Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
- Acute Leukemias – Daniel J. DeAngelo, MD, PhD
- Myelodysplastic Syndrome – David P. Steensma, MD
- Chronic Myelogenous Leukemia – Joseph H. Antin. MD
- Myeloproliferative Syndromes – Ann M. Mullally, MD
- Multiple Myeloma – Kenneth C. Anderson, MD
- Waldenstrom’s Macroglobulemia, Amyloidosis – Irene M. Ghobrial, MD
- Low Grade Lymphomas – Caron A. Jacobson, MD
- High Grade Lymphomas – Arnold S. Freedman, MD
- Hodgkin’s Lymphoma – George P. Canellos, MD
- Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
- Head and Neck Cancer – Robert I. Haddad, MD
- Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD
- Non Small Cell Lung Cancer – Mark Awad, MD, PhD
- Mesothelioma and Thymoma – Geoffrey R. Oxnard, MD
- Thyroid Cancer – Jochen Lorch, MD
- Carcinoid and Pancreatic Neuroendocrine Tumors – Matthew H. Kulke, MD
- Esophageal and Gastric Cancer – Charles S. Fuchs, MD, MPH
- Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD
- Anal Cancers – Robert J. Mayer, MD
- Colorectal Cancers – Robert J. Mayer, MD
- Gastrointestinal Cancer- Genetic Syndromes – Matthew Yurgelun, MD
- Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Christopher J. Sweeney, MBBS
- Renal and Bladder Cancer – Toni K. Choueiri, MD
- Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD
- Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD
- Melanoma – F. Stephen Hodi, MD
- Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD
- Ovarian Cancer – Ursula A. Matulonis, MD
- Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
- Neuro-oncology – David A. Reardon, MD
- Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH
- Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD
- Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD
- Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
- Hematopoiesis and Cytokines – David T. Scadden, MD
- Acquired Bone Marrow Failure – Julie A. Losman. MD
- Congenital Bone Marrow Failure – David A. Williams, MD
- Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
- Anemia: An Overview – Ronald P. McCaffrey, MD
- Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD
- Immune Hemolytic Anemia – Richard M. Kaufman, MD
- Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
- Sickle Cell Disease – Maureen M. Okam, MD, MBBS
- Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
- Disorders of Neutrophils – Nancy Berliner, MD
- Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
- Hemophilia – Ellis J. Neufeld, MD, PhD
- Von Willebrand Disease and Congenital Platelet Disorders – Robert I. Handin, MD
- Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
- New Oral Anticoagulants – Jean M. Connors, MD
- Transfusion Medicine for the Clinician – Walter H. Dzik, MD